NEW YORK (Reuters Health) – There appears to be no increase or decrease in mortality among arthritis patients treated with anti-tumor necrosis factor agents, when compared to standard…
NEW YORK (Reuters Health) – Outcomes of percutaneous coronary intervention are just as good when a loading dose of clopidogrel is given in the cath lab just before…
NEW YORK (Reuters Health) – Revised guidelines on the prevention and treatment of osteoporosis related to glucocorticoid use recommend bisphosphonate therapy but withdraw endorsement of testosterone and estrogen…
NEW YORK (Reuters Health) – Among patients hospitalized for methicillin-resistant Staphylococcus aureus infection, treatment with linezolid is as effective as “gold standard” treatment with vancomycin. In fact, length…
NEW YORK (Reuters Health) – The safety and efficacy of intensive statin therapy initiated soon after a first MI are maintained at 5 years, Scandinavian investigators report. They…
NEW YORK (Reuters Health) – Prospective study results suggest that saquinavir is the only older protease inhibitor (PI) not associated with an increased risk of myocardial infarction (MI).…
NEW YORK (Reuters Health) – When kids have asthma symptoms on moderate doses of inhaled corticosteroids (ICS), adding a long-acting beta-agonist (LABA) achieves the same effect as doubling…
NEW YORK (Reuters Health) – Doctors should make sure immunizations are up to date before cochlear implant surgery in children, new guidelines from the American Academy of Pediatrics…
NEW YORK (Reuters Health) – Patients with febrile neutropenia on high doses of cefepime may be at risk for neurological toxicity, according to a study published online July…
NEW YORK (Reuters Health) – HIV therapy needs to start earlier and guidelines are being changed to reflect that, officials said this weekend at the International AIDS Conference…